Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05594043 |
| Title | A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sanford Cancer Center ( Site 0300) | RECRUITING | Sioux Falls | South Dakota | 57104 | United States | Details |
| Princess Margaret Cancer Centre ( Site 0101) | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
| Centre Hospitalier de l'Université de Montréal-Unit for Innovative Therapies ( Site 0100) | RECRUITING | Montréal | Quebec | H2X 0A9 | Canada | Details |
| Hôpitaux Universitaires de Genève (HUG) ( Site 0202) | RECRUITING | Genève | Geneve | 1211 | Switzerland | Details |
| Ospedale Regionale Bellinzona e Valli ( Site 0200) | RECRUITING | Bellinzona | Ticino | 6500 | Switzerland | Details |
| Cantonal Hospital St.Gallen ( Site 0203) | RECRUITING | Sankt Gallen | 9007 | Switzerland | Details |